HCT-116-luc Orthotopic Model


HCT-116-luc is a luminescent colon cancer cell line derived from HCT-116. It expresses luciferase, allowing for non-invasive monitoring of tumor growth and response to therapies using bioluminescence imaging techniques. HCT-116-luc serves as a valuable tool for studying colon cancer, evaluating drug efficacy, and investigating therapeutic approaches. Researchers utilize this cell line to explore colon cancer biology, identify novel targets, and test anti-cancer agents in preclinical studies.

Model Details

Cancer Type: -B-
Model Name: HCT-116-luc
Mouse Strain: CB.17 SCID
Treatment Data Available: N/A

HCT-116-luc Growth curves

Growth of HCT-116-luc after IP disseminated injection of CB.17 SCID mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content